Literature DB >> 15757150

[Total mesorectal excision by laparoscopy for rectal cancer].

Joel Leroy1, Mara Arenas, Jacques Marescaux.   

Abstract

The treatment of rectal cancer has improved mostly because of the emergence of total mesorectal excision (TME), first described by Heald, and the adjunct of adjuvant therapy in the form of radiotherapy and chemotherapy. Laparoscopy has now been performed for more than a decade with results showing faster return to activity and decreased postoperative pain for intra-abdominal surgery. Laparoscopy is now widely used and is well accepted for the treatment of most intra-abdominal benign pathologies. Furthermore, several authors now report excellent short and medium-term results for the treatment of colorectal cancer. These study tends to show that laparoscopy can be safely applied to digestive malignancies, when oncological principles specific to laparoscopy are respected. The laparoscopic approach is in our opinion a perfect approach for the performance of TME, because of the magnification of structures that it provides, and allows the surgeon to see important structures that need to be identified for the performance of the best oncological and functional procedure possible. This paper describes in a through manner our standardized technique. We also review our own experience with laparoscopic TME, the multimodal treatment of rectal cancer, and provide an analysis of the literature about TME when performed by laparotomy and laparoscopy.

Entities:  

Mesh:

Year:  2004        PMID: 15757150

Source DB:  PubMed          Journal:  Rev Gastroenterol Mex        ISSN: 0375-0906


  2 in total

1.  Laparoscopic resection with intraoperative radiotherapy: a new step in the multimodal treatment of advanced colorectal cancer.

Authors:  I M Civello; C Cavicchioni; R M Tacchino; D Matera; V Valentini; S Manfrida; F Greco
Journal:  Surg Endosc       Date:  2006-11-30       Impact factor: 4.584

2.  Abstracts from the 26th National Congress of the Italian Society of Geriatric Surgery, 19-22 June 2013, Naples, Italy.

Authors: 
Journal:  BMC Surg       Date:  2013-06-19       Impact factor: 2.102

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.